Company Overview and News


Add SPL
to your dashboard

Headline News

Starpharma Shares Jumped on Phase III Results of Vivagel

2017-08-07 biospace
Melbourne, Australia; 7 August 2017: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its two phase 3 trials of VivaGel® BV for prevention of recurrent bacterial vaginosis (rBV) achieved their primary objective demonstrating statistically significant superiority compared to placebo in preventing rBV based on topline data.

News Gets Better, Starpharma Sells Agrochemicals Business: Strategic And Raises $26 Million

2017-06-14 seekingalpha
Starpharma’s Priostar dendrimer technology has been applied to delivery of agricultural products, but it is a distraction to its pharmaceuticals business.

Agrium Acquires Starpharma Holdings' Agrochemical Business

2017-06-14 zacks
Agrium Inc.’s (AGU - Free Report) subsidiary, Loveland Products, Inc. has announced the completion of the acquisition of Starpharma Holdings Limited's agrochemical business for $35 million. The acquired business is focused on developing its proprietary Priostar dendrimer polymer technology portfolio. The transaction includes assets such as key intellectual property and a small number of dedicated staff based in Melbourne, Australia which will support Agrium's innovation and technology strategy.

Agrium Announces Acquisition of Starpharma's Agrochemical Polymer Technology Business

2017-06-13 marketwired
CALGARY, AB--(Marketwired - June 13, 2017) - Agrium Inc. (TSX: AGU) (NYSE: AGU), through its subsidiary Loveland Products, Inc. announced today that it has closed on the acquisition of Starpharma Holdings Limited's agrochemical business focused on development of its proprietary Priostar® dendrimer polymer technology portfolio for $35 million. The acquisition is comprised of key intellectual property, as well as a small number of dedicated staff based in Melbourne, Australia.

Ansell Launches VivaGel Condom In Canada

2017-04-12 devicespace
MELBOURNE, Australia--(BUSINESS WIRE)--Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles® Dual Protect™ brand. These condoms carry the VivaGel® brand and Starpharma will receive royalties based on sales.

Starpharma's VivaGel BV granted QIDP status by FDA

2017-01-12 seekingalpha
Starpharma Holdings (OTCQX:SPHRY) announces that the FDA has granted Qualified Infectious Disease Product (QIDP) and Fast Track status for VivaGel BV (astodrimer sodium) for the treatment and prevention of bacterial vaginosis (BV).

One CEO’s Push to Make Cancer Drugs and Condoms Great Again - Bloomberg

2016-11-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Bacterial Vaginosis Pipeline H2 2016 Market Research Report

2016-08-18 prnewswire
RnRMarketResearch.com adds "Bacterial Vaginosis - Pipeline Review, H2 2016" market research report complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bacterial Vaginosis and special features on late-stage and discontinued projects.

David Jones head office to move to Melbourne

2016-08-05 abc.net.au
The Victorian Government says more than 800 jobs will be created with news South Africa's Woolworths Holdings will set up its Australasian office in Melbourne.

Starpharma Signs License For A VivaGel Condom In China

2016-07-21 devicespace
MELBOURNE, Australia--(BUSINESS WIRE)--Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) today announced the signing of an exclusive license and supply agreement with Shenyang Sky and Land Latex Co. Ltd. (Sky and Land) for the manufacture and sale of VivaGel® condoms to the Government segment of the Chinese condom market. This agreement follows the signing of the MOU with Sky and Land in December 2015.

Colon Cancer Pipeline Market 2016 Review Report Covering Therapeutics Development

2016-07-18 prnewswire
ReportsnReports.com adds "Colon Cancer - Pipeline Review, H1 2016" to its store providing an overview of the Colon Cancer's therapeutic pipeline complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colon Cancer and special features on late-stage and discontinued projects.

Australia’s Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

2016-05-17 biospectrumasia
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics | Reuters

2016-05-16 reuters
SYDNEY Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics

2016-05-16 theedgemarkets
SYDNEY (May 16): Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

'Zika-proof' condoms to be supplied to Australian Olympic team

2016-05-16 telegraph.co.uk
Australian pharmaceutical company Starpharma Holdings said it is teaming up with world number two condom maker Ansell to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Australian Olympians to be given Zika virus-proof condoms at Rio Games | Sport | The Guardian

2016-05-16 theguardian
Fears over spread of virus at the 2016 Olympics prompt collaboration to provide sexually active Australian athletes with near-total protection

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics

2016-05-16 channelnewsasia
SYDNEY: Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics

2016-05-16 channelnewsasia
SYDNEY: Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Starpharma's VivaGel Effective Against Zika Virus

2016-05-05 seekingalpha
Zika virus is of great concern because of the terrible consequences of infection for pregnant women, with a significant risk of severe brain defects, including microencephaly (formation of a small brain). The Zika virus infection usually isn't severe for an infected woman, who may not even be aware she is infected. The infection occurs from being bitten by an Aedes mosquito so this means extreme caution must be taken in areas where the virus is endemic.

VivaGel active against Zika virus

2016-05-05 asx.com.au

Shareholder Update April 2016

2016-04-13 asx.com.au